During the past decade, Szpital Morski im. PCK; Poradnia Onkologiczna conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Szpital Morski im. PCK; Poradnia Onkologiczna" are "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Szpital Morski im. PCK; Poradnia Onkologiczna" in a lesser frequency.

Most popular intervention types in "Szpital Morski im. PCK; Poradnia Onkologiczna" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Giredestrant" (1 trials), "Giredestrant-matched Placebo" (1 trials) and "LHRH Agonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Morski im. PCK; Poradnia Onkologiczna" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Morski im. PCK; Poradnia Onkologiczna". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Szpital Morski im. PCK; Poradnia Onkologiczna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Morski im. PCK; Poradnia Onkologiczna, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".